Drug Type Small molecule drug |
Synonyms ABI 5336 |
Target |
Mechanism HSV-2 Helicase inhibitors(HSV-2 Helicase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Herpesviridae Infections | Preclinical | US | 19 Oct 2023 |